LEADER 04907nam  2200673   450 
001 9910819348103321
005 20200520144314.0
010   $a1-119-04143-0
010   $a1-119-04145-7
010   $a1-119-04144-9
035   $a(CKB)3710000000478595
035   $a(EBL)4040721
035   $a(SSID)ssj0001687195
035   $a(PQKBManifestationID)16526478
035   $a(PQKBTitleCode)TC0001687195
035   $a(PQKBWorkID)15053035
035   $a(PQKB)11512920
035   $a(MiAaPQ)EBC4040721
035   $a(Au-PeEL)EBL4040721
035   $a(CaPaEBR)ebr11113825
035   $a(CaONFJC)MIL833078
035   $a(OCoLC)929527951
035   $a(PPN)223890251
035   $a(EXLCZ)993710000000478595
100   $a20151106h20152015  uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aHandbook of polymers for pharmaceutical technologies$hVolume 3$iBiodegradable polymers /$fedited by Vijay Kumar Thakur and Manju Kumari Thakur
210  1$aHoboken, New Jersey ;$aSalem, Massachusetts :$cScrivener Publishing :$cWiley,$d2015.
210  4$d©2015
215   $a1 online resource (727 p.)
300   $aDescription based upon print version of record.
311   $a1-119-04142-2 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $a""Half Title page""; ""Title page""; ""Copyright page""; ""Dedication""; ""Preface""; ""Chapter 1: Bioactive Polysaccharides of Vegetable and Microbial Origins: An Overview""; ""1.1 Introduction""; ""1.2 Anticarcinogenic Polysaccharides""; ""1.3 Anti-inflammatory/Immunostimulating Polysaccharides""; ""1.4 Antiviral Polysaccharides""; ""1.5 Antioxidant Polysaccharides""; ""1.6 Other Biotechnological Applications""; ""1.7 Conclusions and Future Perspectives""; ""Acknowledgments""; ""References""; ""Chapter 2: Chitosan: An Emanating Polymeric Carrier for Drug Delivery""; ""2.1 Introduction""
327   $a""2.2 Preparation of Chitosan""""2.3 Physicochemical Properties of Chitosan""; ""2.4 Biological Activities of Chitosan""; ""2.5 Pharmaceutical Applications of Chitosan""; ""2.6 Functionalization of Chitosan""; ""2.7 Conclusion and Future Perspectives""; ""References""; ""Chapter 3: Fungi as Sources of Polysaccharides for Pharmaceutical and Biomedical Applications""; ""3.1 Introduction""; ""3.2 The Fungal Cell""; ""3.3 Polysaccharides Produced by Fungi""; ""3.4 Production and Extraction of Polysaccharides from Fungi""
327   $a""3.5 Fungal Polysaccharides in Biomedical and Pharmaceutical Applications""""3.6 Commercial Exploitation of Fungal Polysaccharides in Biomedical and Pharmaceutical Applications""; ""3.7 Conclusion and Future Perspective""; ""References""; ""Chapter 4: Environmentally Responsive Chitosan-based Nanocarriers (CBNs)""; ""4.1 Introduction""; ""4.2 Graft Copolymerized CBNs""; ""4.3 pH-Sensitive CBNs""; ""4.4 Thermosensitive CBNs""; ""4.5 pH-Sensitive and Thermosensitive CBNs""; ""4.6 pH- and Ionic-Sensitive CBNs""; ""4.7 Photosensitive CBNs""; ""4.8 Electrical-Sensitive CBNs""
327   $a""4.9 Magneto-Responsive CBNs""""4.10 Chemo-Sensitive CBNs""; ""4.11 Biodegradation of Chitosan and Its Derivatives""; ""4.12 Toxicity of CBNs""; ""4.13 Conclusions and Future Perspectives""; ""References""; ""Chapter 5: Biomass Derived and Biomass Inspired Polymers in Pharmaceutical Applications""; ""5.1 Introduction""; ""5.2 Biodegradable Polymers in Biomedical Applications - Relevant Aspects""; ""5.3 Biodegradable Natural Polymers in Pharmaceutical Applications""; ""5.4 Micro- and Nanocrystalline Natural Polymers and Fibrils - General Regulative Considerations""
327   $a""5.5 Concluding Remarks and Outlook""""References""; ""Chapter 6: Modification of Cyclodextrin for Improvement of Complexation and Formulation Properties""; ""Abbrevations:""; ""6.1 Introduction""; ""6.2 Cyclodextrin and Its Degradation""; ""6.3 Complexation by CDs and Release""; ""6.4 Modifications and Scope with Respect to Pharmaceutical Application""; ""6.5 Concluding Remarks""; ""Acknowledgements""; ""References""; ""Chapter 7: Cellulose-, Ethylene Oxide- and Acrylic-Based Polymers in Assembled Module Technology (Dome Matrix®)""; ""7.1 Dome Matrix® Technology""
327   $a""7.2 Polymers for Controlled Drug Release""
606   $aPolymers$xTherapeutic use
606   $aPolymers in medicine
606   $aPharmaceutical technology
615  0$aPolymers$xTherapeutic use.
615  0$aPolymers in medicine.
615  0$aPharmaceutical technology.
676   $a572.33
702   $aThakur$b Vijay Kumar
702   $aThakur$b Manju Kumari
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910819348103321
996   $aHandbook of polymers for pharmaceutical technologies$93995159
997   $aUNINA